Invitation to webcast for Q2 2023/2024

2023-11-24 12:30

Biovica, active in cancer diagnostics, publishes its interim report for the second quarter 2023/2024, on November 28 at 08:00 CET. The company invites you to a webcast on the same day at 15.00 CET.

Anders Rylander, CEO, Warren Cresswell, President of Biovica Americas, Henrik Winther, SVP Business Development and Anders Morén, CFO will present and answer questions. Please register for the webcast and watch it live here: link.


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program